Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents
Health Canada has expanded the interim order authorisation for Pfizer and BioNTech’s Covid-19 vaccine to include adolescents aged 12 to 15 years.
Infectious Diseases
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
Novavax reported that the Covid-19 vaccine NVX-CoV2373 offered cross-protection against the B.1.351 variant in the...
Pfizer’s Covid-19 vaccine sales boost revenue in Q1 2021
Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues...
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in...
eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment
eFFECTOR Therapeutics and Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), have announced a $5m cooperative...
Moderna to supply Covid-19 vaccine doses to Gavi
Moderna has entered an agreement with Gavi, the Vaccine Alliance, to deliver up to 500 million doses of its mRNA Covid-19 vaccine to help low- and middle-income countries fight the…
Vaxart’s Covid-19 vaccine shows cross-coronavirus activity in trial
Vaxart has reported the latest data from the Phase I trial of its first Covid-19 oral vaccine construct, VXA-CoV2-1, which showed broad cross-reactivity against other coronaviruses. The open-label study analysed…
Moderna receives emergency use listing from WHO for Covid-19 vaccine
Moderna has received emergency use listing (EUL) from the World Health Organization (WHO) for its Covid-19 vaccine to prevent the disease in individuals aged 18 years and above. Referred to…
Pfizer, BioNTech seek CMA expansion for Covid-19 vaccine in EU
Pfizer and BioNTech have submitted a request to the European Medicines Agency (EMA) to expand Conditional Marketing Authorization (CMA) of their Covid-19 vaccine, COMIRNATY (BNT162b2), in the European Union (EU)…
Human challenge trials: Covid-19 exit strategy or ethical nightmare?
Should you deliberately expose someone to a deadly disease if it could eventually save many lives? That sounds like an ethical minefield and a violation of the Hippocratic Oath –…
MHRA reports 41 blood clot cases after use of AstraZeneca Covid-19 vaccine
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has reported an additional 41 cases of rare blood clots in people who have received doses of AstraZeneca’s Covid-19 vaccine. In…
